From Company Creation through Public Investing
The Frazier Life Sciences team invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to publics.
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.
GSK completes acquisition of Sierra Oncology
Frazier Life Sciences Closes $987 Million Venture Fund to Invest in Companies Developing Novel Biopharmaceuticals
Frazier Healthcare Partners Closes Oversubscribed $830 Million Life Sciences Public Fund
The investments presented herein represent certain investments made by Frazier Life Sciences, but not all investments. A complete list of investments is available upon request.
